Azacitidine administration correlated with clonal expansion and persistence of central memory, as opposed to NKL differentiated TTCR-C4, leading to a prolonged equilibrium between anti-leukemic TTCR-C4 and AML MRD. This evidence concerns the gene C4A and acute myeloid leukemia.